Unlock instant, AI-driven research and patent intelligence for your innovation.

Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars

Inactive Publication Date: 2020-01-30
JENNEWEIN BIOTECHNOLOGIE GMBH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a new process to efficiently produce a single desired monosaccharide in large amounts without negative environmental effects. This allows for the retrieval of the monosaccharide quickly and cost-effectively.

Problems solved by technology

Due to the high chemical similarity of the monosaccharides (mostly differing from each other only by the orientation of individual hydroxyl-groups) the separation of individual monosaccharides in pure form is rather laborious and costly.
Therefore, the isolation of individual monosaccharides from a complex hydrolysate of oligosaccharides is challenging (due to the high chemical similarity of the individual monosaccharides released) and environmentally harmful (due to the excessive use of toxic chemicals, such a lead carbonate).
Also the availability of oligosaccharides rich in a certain sugar can be rather restricted in nature and also highly variable due to seasonal changes.
The large-scale harvest of brown seaweed from sea shores causes environmental concerns and is limited by environmental protection laws.
Generally the yields of these chemical syntheses are often rather poor and involve several chemical steps.
In general, the large-scale chemical synthesis of monosaccharides have not proved economical viable in comparison to extraction of L-fucose from polysaccharides collected from nature.
Thus, currently, the preparation of any monosaccharide in pure form requires a significant effort in the purification of other monosaccharides away from the target monosaccharide, often involving large volumes of organic solvents and other noxious chemicals.
However most microorganisms are restricted in the kinds of monosaccharides they are able to utilize.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars
  • Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars
  • Fermentation process for producing monosaccharides in free form from nucleotide-activated sugars

Examples

Experimental program
Comparison scheme
Effect test

examples

[0083]Construction of a Fucose Producing E. coli Strain

[0084]Escherichia coli BL21 (DE3) (Novagen, Darmstadt, Germany) was used for genetic manipulations to construct the fucose production strain. Since fucose is produced by hydrolysis of GDP-L-fucose, synthesis of GDP-L-fucose is enhanced by genomic integration and overexpression of the genes encoding phosphomannomutase (manB), mannose-1-phosphate guanosyltransferase (manC), GDP-mannose-4,6-dehydratase (gmd), and GDP-L-fucose synthase (wcaG) from E. coli K12 DH5α. The operon manC-manB is under transcriptional control of the Ptet promotor and the operon gmd-wcaG is expressed from the PT5 promotor. The gene cluster tet-manCB-PT5-gmd, wcaG-dhfr> (SEQ ID No. 1; FIG. 4A) comprises also the dhfr gene, encoding a dihydrofolate reductase that confers trimethoprim resistance to the integrants. For integration of the cluster into the E. coli BL21(DE3) genome by transposition, the cluster is flanked by inverted terminal repeats specifically r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a process for producing a monosaccharide, e.g. L-fucose, in free form using a microbial fermentation process. The used microorganism exhibits hydrolase activity on nucleotide-activated sugars and releases the monosaccharide in an unmodified free form. The free monosaccharide is retrieved from the supernatant of the cultivated microorganism.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a Continuation of U.S. application Ser. No. 15 / 546,778, filed Jul. 27, 2017, which is a National Stage entry of International Application No. PCT / EP2016 / 051919, filed Jan. 29, 2016, which claims to European Patent Application No. 15153383.3, filed Jan. 30, 2015.REFERENCE TO SEQUENCE LISTING SUBMITTED AS A COMPLIANT ASCII TEXT FILE (.txt)[0002]Pursuant to the EFS-Web legal framework and 37 CFR §§ 1.821-825 (see MPEP § 2442.03(a)), a Sequence Listing in the form of an ASCII-compliant text file (entitled “Sequence_Listing_3000045-001001_ST25.txt” created on 18 Jul. 2019, and 19,783 bytes in size) is submitted concurrently with the instant application, and the entire contents of the Sequence Listing are incorporated herein by reference.BACKGROUNDField[0003]The present invention relates to a microbial fermentation process for producing a monosaccharide of interest in free form from nucleotide-activated sugars.Description of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12P19/02C12P19/18C12N9/10
CPCC12P19/02C12P19/18C12N9/1051C12N15/63
Inventor JENNEWEIN, STEFANPARSCHAT, KATJA
Owner JENNEWEIN BIOTECHNOLOGIE GMBH